ATTENTION: CONCERNED AMERICANS

Trump's Inner Circle Betting Big on 10 Overlooked Companies

While Wall Street fixates on tariff drama, presidential insiders are quietly amassing positions in specific stocks

URGENT Editor's Note:

Trump's inner circle quietly positioning for massive policy-driven profits

While the media focuses on Trump's tariff battles and Federal Reserve tensions, our investigation has uncovered a far more significant story: presidential insiders are quietly accumulating substantial positions in specific under-the-radar companies positioned to benefit from Trump's policy agenda. From abandoned oil fields to healthcare disruptors and biotech innovators, these companies represent potentially life-changing investment opportunities for those who act before these connections become widely recognized.

Trusted Partner Presentation

Trump's Inside Job

Must Watch Before April 30th
Exposing the President's controlled demolition of the financial markets - and why he could hit the financial detonator any moment now.

Recent market volatility triggered by President Trump's tariff announcements and Federal Reserve comments has dominated financial headlines, but behind the scenes, a more significant story is unfolding. Members of Trump's inner circle—including cabinet members, close advisors, and major financial backers—are reportedly accumulating substantial positions in a small group of under-the-radar companies poised to benefit from the administration's policy agenda.

Abandoned Energy Assets Spring to Life

One of the most striking examples involves a long-dormant California oil field with over 100 ready-to-pump wells that could generate billions in revenue once regulatory barriers are removed. According to financial filings, one of Trump's wealthiest supporters has invested heavily in this asset, even selling personal property to raise additional capital. The project aligns perfectly with Energy Secretary Chris Wright's "drill, baby, drill" agenda and stands to benefit from recent Supreme Court decisions limiting regulatory powers. While this company currently trades for a fraction of its potential value, insiders appear confident that Trump's energy policies will transform this abandoned field into a cash-generating powerhouse.

Special Breaking Presentation
Based on all of these developments, you might want to watch the presentation below from one of our trusted partners.
Trusted Partner Presentation
"THIS IS A GREAT TIME TO BUY!!!" – What Trump Knew
A calendar with a green play button

Did you see Trump's Truth Social post where he called the bottom of the market?

trump truth social stocks

Just three hours later, the NASDAQ surged 12% after he announced a tariff pause.

Investors who followed his advice made a huge gain in a single day.

But here's the thing, the way I see this playing out… This crash and recovery were just Step 1 in Trump's plan.

For those paying attention, he's now signaling an even bigger move for Step 2….

And it could all happen as soon as May 6.

Discover what I think Trump is doing next and why investors who act now stand to make fortunes.

YES, I WANT TO WATCH THIS NOW >>

Healthcare Disruption Accelerates

Family members connected to Trump's son-in-law have founded a healthcare company that's drawing significant insider buying, with over 3.5 million shares purchased since Election Day. The company has already grown from $500 million in revenue in 2020 to nearly $10 billion today by simplifying the insurance experience in ways legacy providers cannot match. As the administration pushes to privatize aspects of healthcare and incentivize efficiency over bureaucracy, this disruptor stands to capture a growing share of the $1.6 trillion health insurance market that constitutes 28% of all federal government spending.

Biotech Firm Benefits from Regulatory Reform

A biotech company majority-owned by one of Trump's closest allies stands to benefit enormously from streamlined FDA approval processes being implemented by Elon Musk's Department of Government Efficiency. The company has developed proprietary software to identify shelved drug compounds with high approval potential, then acquires and shepherds them through the regulatory process. This business model has already proven highly lucrative—one drug purchased for $45 million was later sold for $7.1 billion just seven months after FDA approval. With regulatory barriers falling, the company's pipeline of similar projects could accelerate dramatically in coming years.

RFK Jr.'s Health Initiative Creates Market Winners

RFK Jr.'s "Make America Healthy Again" campaign has already created dramatic shifts in consumer products, with one beverage company seeing its stock surge 200% since Election Day. Despite this rise, the company still trades at just one-times sales, while competitors like Coca-Cola and Monster trade at five times that multiple. With distribution recently expanded to 3,000 Walmart locations (75% of their U.S. stores), this sugar-free alternative shows remarkable growth potential as American health consciousness rises. As RFK Jr. implements his mandate to "wage war" against ingredients he considers harmful, companies aligned with his vision stand to benefit tremendously.

What This Could Mean for Investors

The convergence of policy changes, capital flows, and political will creates a rare opportunity for investors who position themselves before these trends go mainstream. While most market participants focus on obvious plays like Tesla or cryptocurrency, these lesser-known companies connected to Trump's inner circle offer potentially life-changing returns. With insiders already accumulating millions of shares and the administration beginning to implement its agenda through executive orders and agency directives, the window for early positioning is rapidly closing. For investors looking to capitalize on this potential wealth-creation event—regardless of political affiliation—access to comprehensive research on these companies could prove invaluable before their connections to the administration become widely recognized.

×

Sources

  • CNN Business: "Trump was warned of empty shelves and financial turmoil from tariffs and firing Powell. His U-turn pushed stocks higher"
  • Business Insider: "Trump's and Musk's Agendas Have Been Constrained by Reactions in Stocks, Bonds"
  • Fortune: "Markets notch small gains as tech stocks jump and Trump delivers mixed signals on tariffs"
  • Wall Street Journal: "Stock Market Today: Markets eye Trump's next move on tariffs"
  • Barron's: "Time is Running Out for the Stock Market. Trump's Next Move is Crucial"

Donald Trump just won the election resoundingly. And already, in the first few hours after the news, Bitcoin has skyrocketed. Hitting all-time highs on the first day after the election. But that’s just the start …

Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be the greatest bull market in crypto history. He believes Bitcoin will go to $150,000 — or more.

But there’s one coin he thinks could go even higher. It’s part of Trump’s special Project Crypto. His plan to make America “the crypto capital of the planet.” This could be his favorite coin.

And it’s definitely one of his vice president’s favorite. Click here to find out more about the coin that makes more than Bitcoin in the 2025 bull market.

If this article makes sense,
YOU NEED TO WATCH THIS BELOW...
✓ Trusted Partner Presentation
"Partner" with Elon Musk on Project Colossus… Before May 1st

Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you…

To partner with Elon on what he believes will be the biggest AI project of the century…

Starting with as little as $500.

Click here to see how you could take a stake in Elon's private company…

Without having connections in Silicon Valley or having to be an accredited investor.

Image
YES, I WANT TO WATCH THIS NOW >>

TRENDING STORIES

Newsletter Content

Trump identifies 7 unknown tech stocks for $3B ASI project

Early investors could see 5,000%+ returns before this goes public

A leaked document reveals President Trump's plan to invest $3 billion into seven relatively unknown American tech companies for ASI development. These firms specialize in cutting-edge ASI technology—from advanced semiconductor chips to military systems—and remain off most investors' radar.

URGENT: Beyond Targeted Tariffs - Tech's Nuclear Crisis

While markets digest trade lists, true emergency unfolds...

Tech giants are making emergency moves into nuclear while selective tariffs target electronics sectors. Industry insiders reveal tonight's crisis isn't about supply chains - it's about keeping AI systems powered.

Is This Trading Secret Creating Your Next Windfall?

Zero-day options fueling market swings that could create opportunity

Zero-day options trading volume has surged to unprecedented levels, creating volatility rivaling the 2008 crisis. What Wall Street isn't telling you: these contracts now represent 7% of the entire options market.

Disclaimer

MarketsAndPolitics.com a brand under Market Insiders Media dba, operates under the parent company Sandpiper Marketing Group, LLC. Please be advised that MarketsAndPolitics.com is not registered as an investment adviser or broker-dealer with the United States Securities and Exchange Commission or any state regulatory agency. We rely on the "publisher's exclusion" from the definition of investment adviser as set forth in Section 202(a)(11) of the Investment Advisers Act of 1940, as amended, as well as corresponding state securities laws. Consequently, MarketsAndPolitics.com does not offer or provide personalized investment advice. The information we provide is based on our opinions, statistical and financial data, and independent research of public information. Our materials are intended for informational purposes only, and no mention of a specific security in any of our content constitutes a recommendation to buy, sell, or hold that or any other security. Any information deemed to be investment opinion is impersonal and not tailored to the investment needs of any individual. Please be aware that MarketsAndPolitics.com does not promise, guarantee, or imply that any information provided through our websites, newsletters, reports, or printed material will result in profit or loss. We strongly encourage you to seek personal advice from your professional investment, tax, or legal advisors and to conduct your own due diligence and independent investigations before acting on any information we publish or making any investment decision. Only you and your professional advisors can determine the level of risk appropriate for you. Penny stocks, in particular, are inherently speculative investments, and you should be prepared to lose your entire investment. Employees, owners, and/or writers of MarketsAndPolitics.com may own positions in the equities, options, and/or securities mentioned in our content. However, no associated employees will intentionally engage in any transaction that directly or indirectly competes with the interests of our subscribers. MarketsAndPolitics.com may be compensated for publishing information about companies referred to in our reports, newsletters, and websites, and we provide full disclosure of such compensation. Furthermore, please note that any content marked as "Sponsor" may be paid for and is not endorsed or warranted by our staff or company. The content in our emails is for educational or entertainment use and is not a substitute for professional advice or an offer to buy or sell any securities. Neither the publisher nor the editors are registered investment advisors (RIA’s) and do not provide personalized counseling. Be sure to conduct your own careful research and consult with your advisors before taking any action based on our content. By opening our emails or clicking any links contained therein, you are reconfirming your opt-in status, which is part of your free subscription.